Federal Register / Vol. 62, No. 43 / Wednesday, March 5, 1997 / Rules and Regulations 9929

routine matter that will only affect air

traffic procedures and air navigation it

is certified that this rule will not have

significant economic impact on a

substantial number of small entities

under the criteria of the Regulatory

Flexibility Act.

List of Subjects in 14 CFR Part 71

Airspace, Incorporation by reference,

Navigation (air).

Adoption of the Amendment

In consideration of the foregoing, the

Federal Aviation Administration

amends 14 CFR part 71 as follows:

PART 71—[AMENDED]

1. The authority citation for 14 CFR

Part 71 continues to read as follows:

Authority: 49 U.S.C. 106(g), 40103, 40113,

40120; EO 10854, 24 FR 9565, 3 CFR, 1959–

1963 Comp., p. 389; 14 CFR 11.69.

§ 71.1 [Amended]

2. The incorporation by reference in

14 CFR 71.1 of Federal Aviation

Administration Order 7400.9D, Airspace

Designation and Reporting Points, dated

September 4, 1996, and effective

September 16, 1996, is amended as

follows:

Paragraph 6005 Class E airspace areas

extending upward from 700 feet or more

above the surface of the earth.

* * * * *

AEA NY AEA E5 Dunkirk, NY [Revised]

Chautauqua County/Dunkirk Airport, NY

(Lat. 42°29′36′′ N., long. 79°16′19′′ W.)

Angola Airport, NY

(Lat. 42°39′37′′ N., long. 78°59′28′′ W.)

Dunkirk VORTAC, NY

(Lat. 42°29′26′′ N., long. 79°16′27′′ W.)

That airspace extending upward from 700

feet above the surface within a 6.6-mile

radius of Chautauqua County/Dunkirk

Airport and within 11.8-mile radius of the

airport extending clockwise from a 022° to a

264° bearing from the airport and within a

6.3 mile radius of the Angola Airport and

within 5.3 miles northwest of 051° radial

from the Dunkirk VORTAC and within 5.3

miles northwest of the 231° radial from the

VORTAC extending from the 6.3-mile radius

to 9.9 miles southwest of the VORTAC.

* * * * *

Issued in Jamaica, New York on February

21, 1997.

James K. Buckles,

Acting Manager, Air Traffic Division, Eastern

Region.

[FR Doc. 97–5436 Filed 3–4–97; 8:45 am]

BILLING CODE 4910–13–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

21 CFR Part 558

New Animal Drugs for Use in Animal

Feeds; Laidlomycin Propionate

Potassium

AGENCY: Food and Drug Administration,

HHS.

ACTION: Final rule.

SUMMARY: The Food and Drug

Administration (FDA) is amending the

animal drug regulations to reflect

approval of a supplemental new animal

drug application (NADA) filed by

Hoffmann-LaRoche, Inc. The

supplemental NADA provides for use of

dry laidlomycin propionate potassium

Type A articles for making liquid Type

B medicated feeds used to make dry

Type C medicated feeds. The Type C

feeds are for cattle fed in confinement

for slaughter for increased rate of weight

gain and improved feed efficiency.

EFFECTIVE DATE: March 5, 1977.

FOR FURTHER INFORMATION CONTACT:

Russell G. Arnold, Center for Veterinary

Medicine (HFV–142), Food and Drug

Administration, 7500 Standish Pl.,

Rockville, MD 20855, 301–594–1674.

SUPPLEMENTARY INFORMATION: HoffmannLaRoche, Inc., Nutley, NJ 07110, filed

supplemental NADA 141–025, which

provides for use of Cattylyst 50 (50

grams (g) per pound laidlomycin

propionate potassium) dry Type A

articles to make liquid, 100 to 2,000 g

per ton (g/t) laidlomycin propionate

potassium Type B feeds, used to make

dry, 5 to 10 g/t laidlomycin propionate

potassium Type C feeds. The Type C

feeds are for cattle fed in confinement

for slaughter for increased rate of weight

gain and improved feed efficiency. The

supplemental NADA is approved as of

March 5, 1997, and § 558.305 (21 CFR

558.305) is amended to reflect the

approval.

In addition, certain mixing directions

for liquid feeds are required for use of

laidlomycin propionate potassium

liquid Type B feeds to make Type C

feeds. Those directions had not been

previously codified in the regulation. At

this time, existing § 558.305(b) is

redesignated as § 558.305(d) and new

paragraph (b) is added to include those

directions. New § 558.305(c) is

established and reserved for future use.

The supplement is for a new

formulation of an approved product

used to make another approved product.

Approval does not affect the basis of

approval or the conditions of use of the

currently approved application. No

additional safety or effectiveness data

are required. Therefore, a freedom of

information summary is not required. A

summary of safety and effectiveness

data and information submitted to

support approval of the original

application may be seen in the Dockets

Management Branch (HFA–305), Food

and Drug Administration, 12420

Parklawn Dr., rm. 1–23, Rockville, MD

20857, between 9 a.m. and 4 p.m.,

Monday through Friday.

Under section 512(c)(2)(F)(iii) of the

Federal Food, Drug, and Cosmetic Act

(21 U.S.C. 360b(c)(2)(F)(iii)), this

approval does not qualify for marketing

exclusivity because the supplement

does not contain substantial evidence of

effectiveness of the drugs involved, any

studies of animal safety or, in the case

of food-producing animals, human food

safety studies (other than

bioequivalence or residue studies)

required for approval and conducted or

sponsored by the applicant.

The agency has determined under 21

CFR 25.24(d)(1)(iii) that this action is of

a type that does not individually or

cumulatively have a significant effect on

the human environment. Therefore,

neither an environmental assessment

nor an environmental impact statement

is required.

List of Subjects in 21 CFR Part 558

Animal drugs, Animal feeds.

Therefore, under the Federal Food,

Drug, and Cosmetic Act and under

authority delegated to the Commissioner

of Food and Drugs and redelegated to

the Center for Veterinary Medicine, 21

CFR part 558 is amended as follows:

PART 558—NEW ANIMAL DRUGS FOR

USE IN ANIMAL FEEDS

1. The authority citation for 21 CFR

part 558 continues to read as follows:

Authority: Secs. 512, 701 of the Federal

Food, Drug, and Cosmetic Act (21 U.S.C.

360b, 371).

2. Section 558.305 is amended by

redesignating paragraph (b) as paragraph

(d), by adding new paragraphs (b) and

(c), and by revising the title of

redesignated paragraph (d)(3) to read as

follows:

§ 558.305 Laidlomycin propionate

potassium.

* * * * *

(b) Special considerations. (1)

Laidlomycin liquid Type B feeds may be

manufactured from dry laidlomycin

Type A articles. The liquid Type B feeds

must have a pH of 6.0 to 8.0, dry matter

of 62 to 75 percent, and bear appropriate

mixing directions as follows:
9930 Federal Register / Vol. 62, No. 43 / Wednesday, March 5, 1997 / Rules and Regulations

(i) For liquid Type B feeds stored in

recirculating tank systems: Recirculate

immediately prior to use for no less than

10 minutes, moving not less than 1

percent of the tank contents per minute

from the bottom of the tank to the top.

Recirculate daily as described even

when not used.

(ii) For liquid Type B feeds stored in

mechanical, air, or other agitation type

tank systems: Agitate immediately prior

to use for not less than 10 minutes,

creating a turbulence at the bottom of

the tank that is visible at the top. Agitate

daily as described even when not used.

(2) The expiration date for the liquid

Type B feed is 21 days after date of

manufacture. The expiration date for the

dry Type C feed made from the liquid

Type B feed is 7 days after date of

manufacture.

(c) [Reserved]

(d) * * *

(3) Additional limitations. * * *

Dated: February 6, 1997.

Robert C. Livingston,

Director, Office of New Animal Drug

Evaluation, Center for Veterinary Medicine.

[FR Doc. 97–5312 Filed 3–4–97; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HOUSING AND

URBAN DEVELOPMENT

24 CFR Part 203

[Docket No. FR–4032–I–02]

RIN 2502–AG72

Single Family Mortgage Insurance—

Loss Mitigation Procedures

Suspension of Certain Provisions of

Interim Rule

AGENCY: Office of the Assistant

Secretary for Housing—Federal Housing

Commissioner, HUD.

ACTION: Suspension of certain

provisions of interim rule.

SUMMARY: This document suspends,

until the date of publication of a final

rule, the last sentence in introductory

paragraph (a) of 24 CFR 203.355 and the

second sentence in paragraph (f) of 24

CFR 203.402, which otherwise would

have become applicable on March 1,

1997. This suspension is being issued to

permit HUD to consider fully the public

comments on these provisions before

making them applicable. The suspended

provisions relate to loss mitigation

procedures for single family mortgage

insurance.

DATES: Effective February 28, 1997, the

last sentence of the introductory test of

24 CFR 203.355(a) and the second

sentence of 24 CFR 203.402(f) are

suspended.

FOR FURTHER INFORMATION CONTACT:

Joseph McCloskey, Director, Single

Family Servicing Division, Room 9178,

Department of Housing and Urban

Development, 451 7th Street, SW.,

Washington, DC 20410, (202) 708–1672,

or, TTY for hearing and speech

impaired, (202) 708–4594. (These are

not toll-free numbers).

SUPPLEMENTARY INFORMATION: In an

interim rule published on July 3, 1996

(61 FR 35014) to implement loss

mitigation procedures under section 407

of The Balanced Budget Downpayment

Act, I (Pub. L. 104–99, approved January

26, 1996) (Downpayment Act), delayed

implementation dates were included for

provisions in two sections so that HUD

would be able to consider and address

any public comments on these

provisions before the prescribed

implementation date. The reduction

from nine to six months for taking

action upon default of a mortgage in

§ 203.355(a), and the amendment to

§ 203.402(f) to permit varying the

percentage of foreclosure costs or the

costs of acquiring a property that are

reimbursed, were made to apply only

after March 1, 1997.

HUD has determined that it is

appropriate to delay the implementation

of these provisions until the publication

of a final rule. Section 203.355(a)

provides, in part, that ‘‘where the date

of default is on or after March 1, 1997,

the mortgagee shall take one of the

following actions within six months of

the date of default or within such

additional time approved by HUD[.]’’

Section 203.402(f) provides, in part,

that: ‘‘For mortgages insured on or after

March 1, 1997, the Secretary will

reimburse a percentage of foreclosure

costs or costs of acquiring the property,

which percentage shall be determined

in accordance with such conditions as

the Secretary shall prescribe.’’

Accordingly, HUD is providing notice

that is suspending the provision

contained in the last sentence of the

introductory text of paragraph (a) of

§ 203.355 that reduces the foreclosure

initiation time frame from nine months

to six months for mortgages where the

default date is on or after March 1, 1997.

This will leave in place the nine-month

time frame in effect prior to the July 3,

1996 interim rule until HUD issues a

final rule.

In addition, HUD is providing notice

that it is suspending the provision

contained in the second sentence of

§ 203.402(f) that permits HUD to vary

the percentage of foreclose costs or costs

of acquiring the property otherwise

reimbursed for mortgages insured on or

after March 1, 1997. Under this

suspension, HUD will continue to

reimburse foreclosure costs or costs of

acquiring the property otherwise

(including costs of acquiring the

property by the mortgagee and of

conveying and evidencing title to the

property to HUD, but not including any

costs borne by the mortgagee to correct

title defects) actually paid by the

mortgagee and approved by HUD, in an

amount not in excess of two-thirds of

such costs or $75, whichever is the

greater. This will leave in place the

reimbursement rate in effect prior to the

July 3, 1996 interim rule until HUD

issues a final rule.

Dated: February 28, 1997.

Nicolas P. Retsinas,

Assistant Secretary for Housing-Federal

Housing Commissioner.

[FR Doc. 97–5457 Filed 2–28–97; 3:55 pm]

BILLING CODE 4210–27–M

NATIONAL LABOR RELATIONS

BOARD

29 CFR Part 102

Issuance and Service of Subpoenas

AGENCY: National Labor Relations

Board.

ACTION: Final rule.

SUMMARY: The Board is amending its

rules to provide that the Executive

Secretary may sign and issue subpoenas

on behalf of the Board or any Member

thereof and that the date of service of

the subpoena for purposes of computing

the 5-day period for filing a petition to

revoke shall be construed as the date the

subpoena is received.

EFFECTIVE DATE: March 5, 1997.

FOR FURTHER INFORMATION CONTACT: John

J. Toner, Executive Secretary, National

Labor Relations Board, 1099 14th Street,

NW, Room 11600, Washington, DC

20570. Telephone: (202) 273–1940.

SUPPLEMENTARY INFORMATION: For

approximately the last three years, the

NLRB has been conducting an intensive

internal review of its procedures at all

levels of the Agency. The purpose of

this internal review has been to find

ways to maintain and improve the

Agency’s case-processing efficiency in

light of the Agency’s diminishing

resources. Many initiatives have already

been implemented by the Board as part

of this ongoing review, such as the

initiative authorizing the use of

settlement judges and providing judges

with the discretion to dispense with

briefs and to issue bench decisions,